Statins vs. PCSK9 inhibitors: The great debate - Podcast

Teaser description Stephen L. Kopecky, M.D., and R. Scott Wright, M.D., throw down in this debate over best practice and appropriate use of cholesterol-lowering medications.

Congenital heart disease and the management of complex arrhythmias

Mayo Clinic electrophysiologist Christopher J. McLeod, M.B., Ch.B., Ph.D., discusses his approach to the management of complex cardiac arrhythmias in the setting of congenital heart disease in adults.

Virtual reality in medicine: Beyond bulky goggles

Mayo Clinic electrophysiologist Suraj Kapa, M.D.,discusses virtual reality and how this technology is being applied to medicine in this video first shown on Medscape Cardiology.

The lowdown on lipoprotein (a)

Mayo Clinic cardiologists Thomas G. Allison, Ph.D.,and Stephen L. Kopecky, M.D.,discuss lipoprotein (a) and how to address elevated levels in this video first shown on Medscape Cardiology.

Best practices for measuring and managing blood pressure

Mayo Clinic physicians Sandra J. Taler, M.D., Nephrology and Hypertension, and Randal J. Thomas, M.D., Preventive Cardiology, discuss recent American College of Cardiology/American Heart Association blood pressure guidelines in this video ...

Cardiac sarcoidosis

Leslie T. Cooper, M.D., a cardiologist at Mayo Clinic discusses treatment options for patients with cardiac sarcoidosis.

Myocarditis: The great mimicker

Leslie T. Cooper, M.D., a cardiologist at Mayo Clinic discusses prevalence of myocarditis and when to consider a myocarditis diagnosis.

TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone

Mayo Clinic cardiologists Martha Grogan, M.D., and Omar F. Abou Ezzeddine, M.D., C.M., M.S., discuss transthyretin (TTR) amyloidosis and AL amyloidosis.

CABANA post-publication takeaways for catheter ablation of atrial fibrillation

Mayo Clinic electrophysiologists Douglas L. Packer, M.D., Thomas M. Munger, M.D., and Peter A. Noseworthy, M.D., discuss the outcomes, strengths and limitations of the Catheter Ablation versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation ...